In exactly one month, SyVento BioTech will be participating in TIDES USA: Oligonucleotide & Peptide Therapeutics in Boston. This is North America’s leading conference dedicated to advancing oligonucleotide and peptide-based medicines.
We will be represented on site by Sujit Jain, Commercial Advisor, who will be available to discuss collaboration opportunities and our manufacturing capabilities.
Our focus is on delivering robust, regulatory-ready GMP manufacturing solutions, combining high-quality production, analytical excellence, and flexible scale-up to support partners from early clinical stages through commercialization.
If you are attending TIDES USA 2026 and would like to discuss our CDMO solutions or long-term supply partnerships in oligonucleotides and peptides, we look forward to connecting in Boston.
Feel free to reach out to schedule a meeting in advance.
